These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 1493029)

  • 1. Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.
    Goddard MK
    Br J Gen Pract; 1992 Mar; 42(356):120-5. PubMed ID: 1493029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of hormone/estrogen replacement.
    Thomas DJ
    Nurs Clin North Am; 1996 Dec; 31(4):815-25. PubMed ID: 8969341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.
    USPSTF
    Am Fam Physician; 2003 Jan; 67(2):358-64. PubMed ID: 12562158
    [No Abstract]   [Full Text] [Related]  

  • 5. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
    Martin-Du Pan RC; Luzuy F
    Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy.
    Nawaz H; Katz DL
    Am J Prev Med; 1999 Oct; 17(3):250-4. PubMed ID: 10987643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 9. Should women with diabetes mellitus receive hormone replacement therapy?
    Dunne FP
    Int J Clin Pract; 1997; 51(5):299-303. PubMed ID: 9489089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE; Baer-Dubowska W
    Acta Pol Pharm; 2005; 62(3):241-7. PubMed ID: 16193819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopause: refining benefits and risks of hormone replacement therapy.
    Cooper A; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Jun; 7(3):214-9. PubMed ID: 7647275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on hormone replacement therapy.
    Gambrell RD
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-replacement therapy in younger women with breast cancer.
    Theriault RL; Sellin RV
    J Natl Cancer Inst Monogr; 1994; (16):149-52. PubMed ID: 7999457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision factors influencing hormone replacement therapy.
    Rozenberg S; Kroll M; Vandromme J
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():92-7; discussion 97-8. PubMed ID: 8624351
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy, breast and endometrial cancer.
    La Vecchia C
    Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.
    Nason FG; Nelson BE
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):245-70. PubMed ID: 7936544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormone replacement therapy and the risk of breast cancer].
    Hackmon R; Piura B; Mazor M
    Harefuah; 2002 Mar; 141(3):283-6, 313. PubMed ID: 11944224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.